Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn's Disease or Ulcerative Colitis

AuthID
P-00S-ZVK
8
Author(s)
Vermeire, S
·
Lukas, M
·
Adsul, S
·
Lindner, D
·
Rosario, M
·
Roth, J
·
Danese, S
Tipo de Documento
Article
Year published
2020
Publicado
in JOURNAL OF CROHNS & COLITIS, ISSN: 1873-9946
Volume: 14, Número: 8, Páginas: 1066-1073 (8)
Indexing
Publication Identifiers
Pubmed: 32060515
SCOPUS: 2-s2.0-85088402076
Wos: WOS:000582314300007
Source Identifiers
ISSN: 1873-9946
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.